Cytoprotective effect of TRK-100, a prostacyclin analogue, against chemical injuries in cultured human vascular endothelial cells
- 31 December 1989
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 47 (8) , 711-719
- https://doi.org/10.1016/0024-3205(90)90626-3
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Attenuation of Endotoxin-Induced Cytotoxicity and Prostacyclin Production in Cultured Bovine Pulmonary Artery Endothelial Cells by Phosphodiesterase InhibitionExperimental Lung Research, 1988
- Recovery of porcine aortic endothelial cell prostaglandin synthesis following inhibition by sublethal concentrations of hydrogen peroxideBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1987
- Antithrombotic effect of TRK-100, a novel, stable PGI2 analogue.The Japanese Journal of Pharmacology, 1987
- Effect of prostacyclin (PGI2) and a prostaglandin analogue BW 245C on galactosamine-induced hepatic necrosisJournal of Hepatology, 1986
- Glucose toxicity for human endothelial cells in culture. Delayed replication, disturbed cell cycle, and accelerated deathDiabetes, 1985
- Human dermal microvascular endothelial cells in vitro: Effect of cyclic AMP on cellular morphology and proliferation rateJournal of Cellular Physiology, 1981
- Regulation of endothelial cell cyclic nucleotide metabolism by prostacyclin.Journal of Clinical Investigation, 1981
- Recovery of Endothelial Cell Prostacyclin Production after Inhibition by Low Doses of AspirinJournal of Clinical Investigation, 1979
- Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage.Journal of Clinical Investigation, 1978
- Culture of Human Endothelial Cells Derived from Umbilical Veins. IDENTIFICATION BY MORPHOLOGIC AND IMMUNOLOGIC CRITERIAJournal of Clinical Investigation, 1973